rs79753406

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_152753.4(SCUBE3):​c.691A>G​(p.Thr231Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.009 in 1,608,246 control chromosomes in the GnomAD database, including 129 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0072 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0092 ( 125 hom. )

Consequence

SCUBE3
NM_152753.4 missense

Scores

2
15

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.63

Publications

10 publications found
Variant links:
Genes affected
SCUBE3 (HGNC:13655): (signal peptide, CUB domain and EGF like domain containing 3) This gene encodes a member of the signal peptide, complement subcomponents C1r/C1s, Uegf, bone morphogenetic protein-1 and epidermal growth factor-like domain containing protein family. Overexpression of this gene in human embryonic kidney cells results in secretion of a glycosylated form of the protein that forms oligomers and tethers to the cell surface. This gene is upregulated in lung cancer tumor tissue compared to healthy tissue and is associated with loss of the epithelial marker E-cadherin and with increased expression of vimentin, a mesenchymal marker. In addition, the protein encoded by this gene is a transforming growth factor beta receptor ligand, and when secreted by cancer cells, it can be cleaved in vitro to release the N-terminal epidermal growth factor-like repeat domain and the C-terminal complement subcomponents C1r/C1s domain. Both the full length protein and C-terminal fragment can bind to the transforming growth factor beta type II receptor to promote the epithelial-mesenchymal transition and tumor angiogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
SCUBE3-AS1 (HGNC:56671): (SCUBE3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010085374).
BP6
Variant 6-35233280-A-G is Benign according to our data. Variant chr6-35233280-A-G is described in ClinVar as Benign. ClinVar VariationId is 708924.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00721 (1091/151336) while in subpopulation EAS AF = 0.0143 (73/5122). AF 95% confidence interval is 0.0116. There are 4 homozygotes in GnomAd4. There are 554 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152753.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCUBE3
NM_152753.4
MANE Select
c.691A>Gp.Thr231Ala
missense
Exon 6 of 22NP_689966.2
SCUBE3
NM_001303136.2
c.688A>Gp.Thr230Ala
missense
Exon 6 of 22NP_001290065.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCUBE3
ENST00000274938.8
TSL:1 MANE Select
c.691A>Gp.Thr231Ala
missense
Exon 6 of 22ENSP00000274938.7Q8IX30-1
SCUBE3
ENST00000889524.1
c.691A>Gp.Thr231Ala
missense
Exon 6 of 23ENSP00000559583.1
SCUBE3
ENST00000940915.1
c.688A>Gp.Thr230Ala
missense
Exon 6 of 23ENSP00000610974.1

Frequencies

GnomAD3 genomes
AF:
0.00721
AC:
1091
AN:
151218
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00185
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0105
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.0140
Gnomad SAS
AF:
0.0107
Gnomad FIN
AF:
0.00343
Gnomad MID
AF:
0.0223
Gnomad NFE
AF:
0.00919
Gnomad OTH
AF:
0.0144
GnomAD2 exomes
AF:
0.00868
AC:
2179
AN:
251146
AF XY:
0.00956
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00686
Gnomad ASJ exome
AF:
0.0134
Gnomad EAS exome
AF:
0.00707
Gnomad FIN exome
AF:
0.00319
Gnomad NFE exome
AF:
0.00992
Gnomad OTH exome
AF:
0.0109
GnomAD4 exome
AF:
0.00919
AC:
13391
AN:
1456910
Hom.:
125
Cov.:
30
AF XY:
0.00939
AC XY:
6810
AN XY:
725018
show subpopulations
African (AFR)
AF:
0.00174
AC:
58
AN:
33336
American (AMR)
AF:
0.00739
AC:
330
AN:
44654
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
351
AN:
26042
East Asian (EAS)
AF:
0.0347
AC:
1371
AN:
39552
South Asian (SAS)
AF:
0.0132
AC:
1140
AN:
86178
European-Finnish (FIN)
AF:
0.00385
AC:
205
AN:
53222
Middle Eastern (MID)
AF:
0.0294
AC:
169
AN:
5748
European-Non Finnish (NFE)
AF:
0.00830
AC:
9201
AN:
1108008
Other (OTH)
AF:
0.00941
AC:
566
AN:
60170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
615
1231
1846
2462
3077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00721
AC:
1091
AN:
151336
Hom.:
4
Cov.:
31
AF XY:
0.00749
AC XY:
554
AN XY:
73940
show subpopulations
African (AFR)
AF:
0.00184
AC:
76
AN:
41198
American (AMR)
AF:
0.0104
AC:
159
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3464
East Asian (EAS)
AF:
0.0143
AC:
73
AN:
5122
South Asian (SAS)
AF:
0.0105
AC:
50
AN:
4746
European-Finnish (FIN)
AF:
0.00343
AC:
36
AN:
10488
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.00919
AC:
623
AN:
67780
Other (OTH)
AF:
0.0143
AC:
30
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
50
100
150
200
250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00933
Hom.:
39
Bravo
AF:
0.00694
TwinsUK
AF:
0.00485
AC:
18
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00942
AC:
81
ExAC
AF:
0.00894
AC:
1086
Asia WGS
AF:
0.0100
AC:
35
AN:
3478
EpiCase
AF:
0.0121
EpiControl
AF:
0.0127

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
20
DANN
Benign
0.94
DEOGEN2
Benign
0.063
T
Eigen
Benign
-0.50
Eigen_PC
Benign
-0.28
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-0.68
T
MutationAssessor
Benign
0.21
N
PhyloP100
1.6
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.97
N
REVEL
Benign
0.17
Sift
Benign
0.37
T
Sift4G
Benign
0.43
T
Polyphen
0.083
B
Vest4
0.23
MVP
0.81
MPC
0.77
ClinPred
0.020
T
GERP RS
4.6
Varity_R
0.092
gMVP
0.43
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79753406; hg19: chr6-35201057; COSMIC: COSV51457121; API